Table 1.
Mean (SD) | Varenicline n = 420 | Placebo n = 408 | p-value |
---|---|---|---|
Age | 44.95 (11.71) | 45.73 (11.07) | .33 |
Mean baseline CPD | 16.73 (6.00) | 17.31 (7.68) | .22 |
FTND | 5.10 (2.01) | 5.36 (1.96) | .06 |
Percent | |||
Female | 44.52 | 42.65 | .59 |
POC | 43.57 | 41.91 | .79 |
Race n | .52 | ||
White/Caucasian | 232 | 225 | |
Black/African American | 160 | 151 | |
Asian | 14 | 13 | |
Other | 8 | 7 | |
Multi-racial | 5 | 12 | |
American Indian | 1 | 0 | |
Ethnicity n | .31 | ||
Non-Hispanic/Non-Latinx | 398 | 382 | |
Hispanic/Latinx | 19 | 25 | |
Missing/did not disclose | 3 | 1 |
Differences assessed using one-way ANOVA and chi-square tests. CPD = cigarettes per day. FTND = Fagerstrom test for nicotine dependence. POC = people of color.